Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Relling

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Clinical Pharmacology and Therapeutics|July 4, 2013
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancerJ J Yang, J Y S Lim, J Huang, et al.
Leukemia|December 17, 2009
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, D Pei, J T Sandlund, et al.
Clinical Pharmacology and Therapeutics|September 20, 2012
A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical recordJ K Hicks, K R Crews, J M Hoffman, et al.
Clinical Pharmacology and Therapeutics|March 4, 2011
Functional characterization of liver enhancers that regulate drug-associated transportersM J Kim, P Skewes-Cox, H Fukushima, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprineW E Evans, Y Y Hon, L Bomgaars, et al.
Leukemia|August 27, 2011
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapyD Bhojwani, D Pei, J T Sandlund, et al.
Clinical Pharmacology and Therapeutics|August 27, 2016
Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic TraitC Liu, W Yang, D Pei, et al.
Leukemia|May 1, 2014
A revised definition for cure of childhood acute lymphoblastic leukemiaC H Pui, D Pei, D Campana, et al.
Leukemia|January 19, 2017
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemiaS E Karol, E Larsen, C Cheng, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Clinical Pharmacology and Therapeutics|July 4, 2013
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancerJ J Yang, J Y S Lim, J Huang, et al.
Leukemia|December 17, 2009
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, D Pei, J T Sandlund, et al.
Clinical Pharmacology and Therapeutics|September 20, 2012
A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical recordJ K Hicks, K R Crews, J M Hoffman, et al.
Clinical Pharmacology and Therapeutics|March 4, 2011
Functional characterization of liver enhancers that regulate drug-associated transportersM J Kim, P Skewes-Cox, H Fukushima, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprineW E Evans, Y Y Hon, L Bomgaars, et al.
Leukemia|August 27, 2011
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapyD Bhojwani, D Pei, J T Sandlund, et al.
Clinical Pharmacology and Therapeutics|August 27, 2016
Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic TraitC Liu, W Yang, D Pei, et al.
Leukemia|May 1, 2014
A revised definition for cure of childhood acute lymphoblastic leukemiaC H Pui, D Pei, D Campana, et al.
Leukemia|January 19, 2017
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemiaS E Karol, E Larsen, C Cheng, et al.
Pageof 18